- Scheduled from June 13th to 15th, 2024, at the India International Convention Centre (IICC) in Dwarka, New Delhi
- Born of the legacy of Arab Health, the debut of the India Health Expo, featuring over 300 brands, marks a pivotal moment for the healthcare industry
Informa Markets in India proudly announces the debut of its much-awaited expo, India Health, scheduled from June 13th to 15th, 2024, at the India International Convention Centre (IICC) in Dwarka, New Delhi. This inaugural event marks a pivotal moment for the healthcare industry, promising to create benchmarks and collaborative advancement.
Born of the esteemed legacy of globally renowned events like Arab Health and Asia Health, India Health envisions itself as bringing the entire Healthcare Industry under one platform., enabling businesses in delivering equitable healthcare nationwide.
The premier edition of India Health will showcase over 300 leading global and domestic brands across Medical Equipment & Devices, Orthopaedics & Physiotherapy, Imaging & Diagnostics, Healthcare & General Services, IT Systems & Solutions, Healthcare Infrastructure & Assets, Wellness & Prevention, and more. Major industry players including KLS Martin group, Medikabazaar, Midmark and Narang Medical LTD have confirmed their participation, with support from esteemed associations such as ADMI, AHPI, and MTAI.
Emphasizing the significance of India Health, Mr Yogesh Mudras, Managing Director of Informa Markets in India, stated, “India Health is the heartbeat of our shows. There’s never been a more opportune moment to launch such a groundbreaking event with India’s healthcare sector rapidly expanding and projected to reach US$638 billion by 2025. This has been driven by incremental healthcare coverage, investments, and enhanced services from both public and private sectors. Government initiatives, such as relaxed FDI norms, startup promotion policies, and bolstered R&D efforts, alongside refined IPR regulations, have fostered a conducive business environment.
India Health aligns seamlessly with the ‘Make in India’ campaign, focusing on vital sectors like pharmaceuticals, biotechnology, and chemicals. The expo stands at the convergence for advancing healthcare excellence, innovation, and promoting collaboration, all while addressing the nation’s health needs equitably. With its inaugural edition, we anticipate a profound impact and extend our gratitude to all stakeholders for their unwavering support,” he added.
India Health will attract a distinguished visitor profile comprising biomedical engineers, hospital consultants, distributors, doctors, clinicians, procurement heads, regulatory bodies, and policymakers. The event will also feature the official country pavilion of Hungary, enriching attendees with diverse perspectives and innovations.
Enhancing the attendee experience, India Health will include a Transformation Zone showcasing start-up companies and innovators with transformative products and new launches. Additionally, Start-up Pavilions will provide domestic entrepreneurs the opportunity to engage with industry experts and potential investors.
A robust 3-day educational programme comprising 15 conferences will complement India Health, covering critical areas such as imaging and diagnostics, public-private partnerships, primary care, and more, aligning with India’s healthcare strategy and vision.
The sector, at a glance:
- India ranks as the 4th largest medical device market globally.
- The industry is projected to reach a valuation of US$638 billion by 2025
- Public health spending is projected to grow to 2.5% of the country’s GDP.
- The Indian medical tourism industry is estimated to surpass US$42 billion by 2032.
- Over $200 billion is earmarked for medical infrastructure spending by 2024.
- The medtech market in India is projected to reach $50 billion by 2025.
- Non-communicable diseases account for 7 out of the top causes of death in India.
- 70% of the population resides in rural areas, with access to less than 30% of healthcare infrastructure.
